Ahmad, F, Rossen, L, Spence, M, Warner, M and Sutton, P (2017) Provisional Drug Overdose Death Counts. National Center for Health Statistics.
Ashrafioun, L, Bishop, TM, Conner, KR and Pigeon, WR (2017) Frequency of prescription opioid misuse and suicidal ideation, planning, and attempts. Journal of Psychiatric Research 92, 1–7.
Ashrafioun, L, Kane, C, Bishop, TM, Britton, PC and Pigeon, WR (2019) The association of pain intensity and suicide attempts among patients initiating pain specialty services. Journal of Pain 20, 852–859.
Barry, DT, Cutter, CJ, Beitel, M, Kerns, RD, Liong, C and Schottenfeld, RS (2016) Psychiatric disorders among patients seeking treatment for co-occurring chronic pain and opioid use disorder. Journal of Clinical Psychiatry 77, 1413–1419.
Blanco, C, Miran, I, Schwartz, RP, Rafful, C, Wang, S and Olfson, M (2013) Probably and predictors of treatment-seeking for prescription opioid use disorder: a national study. Drug and Alcohol Dependence 131, 143–148.
Bohnert, AS, Valenstein, M, Bair, MJ, Ganoczy, D, McCarthy, JF, Ilgen, MA and Blow, FC (2011) Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA 305, 1315–1321.
Bohnert, KM, Ilgen, MA, Louzon, S, McCarthy, JF and Katz, IR (2017) Substance use disorders and the risk of suicide mortality among men and women in the US Veterans Health Administration. Addiction 112, 1193–1201.
Braden, JB, Sullivan, MD, Ray, GT, Saunders, K, Merril, J, Silverberg, MJ, Rutter, CM, Weisner, C, Banta-Green, C, Campbell, C and Von Korff, M (2009) Trends in long-term opioid therapy for noncancer pain among persons with a history of depression. General Hospital Psychiatry 31, 564–570.
Braden, JB, Edlund, MJ and Sullivan, MD (2017) Suicide deaths with opioid poisoning in the United States: 1999–2014. American Journal of Public Health 107, 421–426.
Britton, PC, Stephens, B, Wu, J, Kane, C, Gallegos, A, Ashrafioun, L, Tu, X and Conner, KR (2015) Comorbid depression and alcohol use disorders and prospective risk for suicide attempt in the year following inpatient hospitalization. Journal of Affective Disorders 187, 151–155.
Buck, CJ (2013) ICD-9-CM for Physicians. St. Louis, MO: Elsevier Health Sciences.
Carpentier, PJ, Krabbe, PF, van Gogh, MT, Knapen, LJ, Buitelaar, JK and de Jong, CA (2009) Psychiatric comorbidity reduces quality of life in chronic methadone maintained patients. American Journal on Addictions 18, 470–480.
Conner, KR and Ilgen, MA (2016) Substance use disorders and suicidal behavior: a conceptual model. In O'Connor, RC and Pirkis, J (eds), pp. 110–123. The International Handbook of Suicide Prevention. Chichester, UK: John Wiley & Sons.
Department of Veterans Affairs Office of Suicide Prevention (2018) .
Dowell, D, Arias, E, Kochanek, K, Anderson, R, Guy, GP Jr, Losby, JL and Baldwin, G (2017). Contribution of opioid-involved poisoning to the change in life expectancy in the United States, 2000–2015. JAMA 318, 1065–1067.
Elman, I, Borsook, D and Volkow, ND (2013) Pain and suicidality: insights from reward and addiction neuroscience. Progress in Neurobiology 109, 1–27.
Franklin, JC, Ribeiro, JD, Fox, KR, Bentley, KH, Kleiman, EM, Huang, X, Musacchio, KM, Jaroszewski, AC, Chang, BP and Nock, MK (2017) Risk factors for suicidal thoughts and behaviors: a meta-analysis of 50 years of research. Psychological Bulletin 143, 187–232.
Gagne, JJ, Glynn, RJ, Avorn, J, Levin, R and Schneeweiss, S (2011) A combined comorbidity score predicted mortality in elderly patients better than existing scores. Journal of Clinical Epidemiology 64, 749–759.
Garland, EL, Manusov, EG, Froeliger, B, Kelly, A, Williams, JM and Howard, MO (2014) Mindfulness-oriented recovery enhancement for chronic pain and prescription opioid misuse: results from an early-stage randomized controlled trial. Journal of Consulting and Clinical Psychology 82, 448–459.
Glenn, CR, Kleiman, EM, Cha, CB, Deming, CA, Franklin, JC and Nock, MK (2018) Understanding suicide risk within the research domain criteria (RDoC) framework: a meta-analytic review. Depression and Anxiety 35, 65–88.
Gradus, JL, Qin, P, Lincoln, AK, Miller, M, Lawler, E, Sorensen, HT and Lash, TL (2010) Posttraumatic stress disorder and completed suicide. American Journal of Epidemiology 171, 721–727.
Harris, AH, Oliva, E, Bowe, T, Humphreys, KN, Kivlahan, DR and Trafton, JA (2012) Pharmacotherapy of alcohol use disorders by the veterans health administration: patterns of receipt and persistence. Psychiatric Services 63, 679–685.
Harris, AH, Bowe, T, Del Re, AC, Finlay, AK, Oliva, E, Myrick, HL and Rubinsky, AD (2015) Extended release naltrexone for alcohol use disorders: quasi-experimental effects on mortality and subsequent detoxification episodes. Alcoholism: Clinical and Experimental Research 39, 79–83.
Hedegaard, H, Curtin, SC and Warner, M (2018) Suicide rates in the United States continue to increase. NCHS Databrief, June, 1–8.
Hoffmire, C, Stephens, B, Morley, S, Thompson, C, Kemp, J and Bossarte, RM (2016) VA suicide prevention applications network: a national health care system-based suicide event tracking system. Public Health Report 131, 816–821.
Ilgen, MA, Bohnert, AS, Ignacio, RV, McCarthy, JF, Valenstein, MM, Kim, HM and Blow, FC (2010) Psychiatric diagnoses and risk of suicide in veterans. Archives of General Psychiatry 67, 1152–1158.
Ilgen, MA, Bohnert, AS, Chermack, S, Conran, C, Jannausch, M, Trafton, J and Blow, FC (2016) A randomized trial of a pain management intervention for adults receiving substance use disorder treatment. Addiction 111, 1385–1393.
Kerns, RD, Philip, EJ, Lee, AW and Rosenberger, PH (2011) Implementation of the veterans health administration national pain management strategy. Translational Behavioral Medicine 1, 635–643.
Klonsky, ED and May, AM (2015) The three-step theory (3ST): a new theory of suicide rooted in the “ideation-to-action” framework. International Journal of Cognitive Therapy 8, 114–129.
Li, R and Chambless, L (2007) Test for additive interaction in proportional hazard models. Annals of Epidemiology 17, 227–236.
Lipari, RN, Williams, M and Van Horn, SL (2017) , pp. 1–10.
Ma, J, Bao, YP, Wang, RJ, Su, MF, Liu, MX, Li, JQ, Degenhardt, L, Farrell, M, Blow, FC, Ilgen, M, Shi, J and Lu, L (2018) Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis. Molecular Psychiatry. .
Maloney, E, Degenhardt, L, Darke, S, Mattick, RP and Nelson, E (2007) Suicidal behaviour and associated risk factors among opioid-dependent individuals: a case-control study. Addiction 102, 1933–1941.
Martins, SS, Keyes, KM, Storr, CL, Zhu, H and Chilcoat, HD (2009) Pathways between nonmedical opioid use/dependence and psychiatric disorders: results from the national epidemiologic survey on alcohol and related conditions. Drug and Alcohol Dependence 103, 16–24.
Martins, SS, Fenton, MC, Keyes, KM, Blanco, C, Zhu, H and Storr, CL (2012) Mood and anxiety disorders and their association with non-medical prescription opioid use and prescription opioid-use disorder: longitudinal evidence from the national epidemiologic study on alcohol and related conditions. Psychological. Med 42, 1261–1272.
Nock, MK, Hwang, I, Sampson, NA and Kessler, RC (2010) Mental disorders, comorbidity and suicidal behavior: results from the national comorbidity survey replication. Molecular Psychiatry 15, 868–876.
Olfson, M, Wall, M, Wang, S, Crystal, S, Gerhard, T and Blanco, C (2017) Suicide following deliberate self-harm. American Journal of Psychiatry 174, 765–774.
Oliva, EM, Harris, AH, Trafton, JA and Gordon, AJ (2012) Receipt of opioid agonist treatment in the veterans health administration: facility and patient factors. Drug and Alcohol Dependence 122, 241–246.
Opioid Therapy for Chronic Pain Work Group (2017) .
Painter, JM, Brignone, E, Gilmore, AK, Lehavot, K, Fargo, J, Suo, Y, Simpson, T, Carter, ME, Blais, RK and Gundlapalli, AV (2018) High inpatient utilization among veterans health administration patients with substance use disorders and co-occurring mental health conditions. American Journal of Drug and Alcohol Abuse 44, 386–394.
Rockett, IR, Smith, GS, Caine, ED, Kapusta, ND, Hanzlick, RL, Larkin, GL, Naylor, CP, Nolte, KB, Miller, TR, Putnam, SL, De Leo, D, Kleinig, J, Stack, S, Todd, KH and Fraser, DW (2014) Confronting death from drug self-intoxication (DDSI): prevention through a better definition. American Journal of Public Health 104, e49–e55.
Scherrer, JF, Salas, J, Copeland, LA, Stock, EM, Ahmedani, BK, Sullivan, MD, Burroughs, T, Schneider, FD, Bucholz, KK and Lustman, PJ (2016a) Prescription opioid duration, dose, and increased risk of depression in 3 large patient populations. Annals of Family Medicine 14, 54–62.
Scherrer, JF, Salas, J, Copeland, LA, Stock, EM, Schneider, FD, Sullivan, M, Bucholz, KK, Burroughs, T and Lustman, PJ (2016b) Increased risk of depression recurrence after initiation of prescription opioids in noncancer pain patients. Journal of Pain 17, 473–482.
Shepard, DS, Gurewich, D, Lwin, AK, Reed, GA Jr and Silverman, MM (2016). Suicide and suicidal attempts in the United States: costs and policy implications. Suicide and Life Threatening Behaviors 46, 352–362.
Shurman, J, Koob, GF and Gutstein, HB (2010) Opioids, pain, the brain, and hyperkatifeia: a framework for the rational use of opioids for pain. Pain Medicine 11, 1092–1098.
Stanley, B, Brown, GK, Brenner, LA, Galfalvy, HC, Currier, GW, Knox, KL, Chaudhury, SR, Bush, AL and Green, KL (2018) Comparison of the safety planning intervention with follow-up vs usual care of suicidal patients treated in the emergency department. JAMA Psychiatry 75, 894–900.
Sullivan, MD (2018) Depression effects on long-term prescription opioid use, abuse, and addiction. Clinical Journal of Pain 34, 878–884.